The NDA Summer Data Submission Cycle deadline is July 15, 2022
For investigators submitting data for the first time, please visit our website to identify the applicable Data Sharing Terms and Conditions.
Data submission can start at any time, so prepare early to allow our Data Curation team sufficient time to align your data collection instruments to the NDA Data Dictionary. Don't wait to get your data in order. Start early!
The Data Sharing Terms and Conditions state that all new NDA Collections must define their Data Expected list within 6 months of the NIH award start date. If you have not completed your Data Expected list by now, please contact the NDA Help Desk to alert us that you are not able to submit data on time and we can help you get on track.
As always, you can email the NDA Help Desk for assistance with Data Submission.
Be sure to validate and upload your data to meet the submission deadline!
If you have questions - we have answers!
Office Hours are designated times for our experts to answer your specific NDA Collection questions in real-time.
We encourage all NDA users required to submit data by the July 15th, 2022, submission cycle deadline to join us for at least one session. These sessions are an opportunity to learn about the entire NDA data submission process and to receive specialized guidance for your NDA Collection!
To join one of our upcoming Office Hour sessions, simply register on our website.
Feel free to share this information with the appropriate staff on your project.
As always, you can email the NDA Help Desk with any questions! NDA Help Desk hours are weekdays from 8:30am-5:30pm EST.
|
NIH prepares for new Data Management and Sharing Policy (DMSP)
Coming in January 2023, a new NIH policy will require a detailed statement on Data Management and Sharing to be submitted with grant applications. The policy promotes responsible stewardship of data and follows years of public commentary and preparation. Users of the NIMH Data Archive (NDA) have a head start on data stewardship and should find alignment of NDA practices and the details required for reporting in the novel DMSP section of applications. Please review the policy here.
All NDA Collections have a Data Expected list prepopulated with one or more of the following mandatory Data Structures upon NDA Collection creation:
- Research Subject and Pedigree (RS&P): All core information about study subjects. All Collections except those submitting omics data should use NDA's Research Subject structure.
Collections submitting omics data should use NDA's Genomics Subject structure.
NIH Common Data Elements (CDEs)
NIH CDEs are NDA required Data Structures for NDA Collections subject to NOT-MH-20-067. In addition to the Research Subject & Pedigree Data Structure, the following Data Structures may be added to your Data Expected list:
If the subjects of the study are children under 18, then in addition to the Research Subject and Pedigree Data Structure, the following will be added:
- RCADS-25 Parents/Caregiver Report
- RCADS-25 Youth Self-Assessment
Data collected using each of the required Data Structures in your Data Expected list must be submitted!
- Collections from special projects such as OAI or ABCD may require their own mandatory Data Structure(s).
- If you want to alter that initial set of Data Structures, please submit a ticket via email to the NDA Help Desk with a justification for the change.
- Requests for not collecting data for any of the required Data Structures should be sent to your Program Officer (PO) and/or to Gregory K. Farber, Ph.D. at farberg@mail.nih.gov for approval.
Researcher Auth Service (RAS) is a cloud-based authentication and authorization service that facilitates access to NIH’s open and controlled data assets and repositories in a consistent, secure, and user-friendly manner.
To reduce the burden on researchers’ access to NIH data while increasing the security of controlled data access, the NIH Office of Data Science Strategy (ODSS) and the Center for Information Technology (CIT) are collaborating on the Researcher Auth Service (RAS) initiative.
Please refer to our website for more information on RAS and how it affects you.
|
AMPSCZ Website Launch
The AMPSCZ project has set up a new website! The Accelerating Medicines Partnership (AMP®) program is a public-private partnership between the National Institutes of Health, the U.S. Food and Drug Administration, the European Medicines Agency, pharmaceutical and life science companies, non-profit and other organizations. The AMP Schizophrenia (SCZ) program was launched in 2020 to address the critical need for more effective treatments for people with schizophrenia and related mental health conditions.
The new website features information about the study and provides resources for clinicians and scientists.
To learn more, visit https://www.ampscz.org/ and https://nda.nih.gov/ampscz.
|
|
